Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Index
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - KalVista Pharmaceuticals (NASDAQ: KALV)
Follow
NASDAQ:KALV
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
KALV
KalVista Pharmaceuticals
Palleiko Benjamin L
/
director, officer: CHIEF EXECUTIVE OFFICER
12/09/2024
Sell
$9.75
7,627
$74K
274,596
NASDAQ
KALV
KalVista Pharmaceuticals
Audhya Paul K.
/
officer: CHIEF MEDICAL OFFICER
11/26/2024
Sell
$9.87
2,187
$22K
97,012
NASDAQ
KALV
KalVista Pharmaceuticals
Yea Christopher
/
officer: CHIEF DEVELOPMENT OFFICER
11/26/2024
Sell
$9.87
1,963
$19K
91,142
NASDAQ
KALV
KalVista Pharmaceuticals
Reid Laurence
/
director
11/23/2024
Buy
$10.07
17,000
$171K
17,000
NASDAQ
KALV
KalVista Pharmaceuticals
Palleiko Benjamin L
/
director, officer: CHIEF EXECUTIVE OFFICER
11/18/2024
Sell
$9.26
14,400
$133K
266,598
NASDAQ
KALV
KalVista Pharmaceuticals
Yea Christopher
/
officer: CHIEF DEVELOPMENT OFFICER
11/18/2024
Sell
$9.26
7,192
$67K
89,980
NASDAQ
KALV
KalVista Pharmaceuticals
Audhya Paul K.
/
officer: CHIEF MEDICAL OFFICER
11/18/2024
Sell
$9.26
8,077
$75K
94,199
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2025
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily Life Science Stock News
Register
or
Login
to Access Entire Platform.